Pranav S Garimella1, Ronit Katz1, Kushang V Patel1, Stephen B Kritchevsky1, Chirag R Parikh1, Joachim H Ix1, Linda F Fried1, Anne B Newman1, Michael G Shlipak1, Tamara B Harris1, Mark J Sarnak2. 1. From the Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA (P.S.G., M.J.S.); Kidney Research Institute (R.K.) and Department of Anesthesiology and Pain Medicine (K.V.P.), University of Washington, Seattle; Sticht Center on Aging, Wake Forest School of Medicine, Winston-Salem, NC (S.B.K.); Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, CT (C.R.P.); Nephrology Section, Veterans Affairs San Diego Healthcare System and Division of Nephrology and Preventive Medicine, University of California, San Diego (J.H.I.); Renal Section, VA Pittsburgh Healthcare System (L.F.F.) and Department of Epidemiology, Graduate School of Public Health (A.B.N.), University of Pittsburgh, PA; Department of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco (M.G.S.); Department of General Internal Medicine, San Francisco VA Medical Center, CA (M.G.S.); and Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MA (T.B.H.). 2. From the Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA (P.S.G., M.J.S.); Kidney Research Institute (R.K.) and Department of Anesthesiology and Pain Medicine (K.V.P.), University of Washington, Seattle; Sticht Center on Aging, Wake Forest School of Medicine, Winston-Salem, NC (S.B.K.); Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, CT (C.R.P.); Nephrology Section, Veterans Affairs San Diego Healthcare System and Division of Nephrology and Preventive Medicine, University of California, San Diego (J.H.I.); Renal Section, VA Pittsburgh Healthcare System (L.F.F.) and Department of Epidemiology, Graduate School of Public Health (A.B.N.), University of Pittsburgh, PA; Department of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco (M.G.S.); Department of General Internal Medicine, San Francisco VA Medical Center, CA (M.G.S.); and Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MA (T.B.H.). msarnak@tuftsmedicalcenter.org.
Abstract
BACKGROUND: Studies suggest that in patients with heart failure (HF), high serum erythropoietin is associated with risk of recurrent HF and mortality. Trials of erythropoietin-stimulating agents in persons with kidney disease have also suggested an increased incidence of adverse clinical events. No large studies of which we are aware have evaluated the association of endogenous erythropoietin levels with clinical outcomes in the community-living older adults. METHODS AND RESULTS: Erythropoietin concentration was measured in 2488 participants aged 70-79 years in the Health, Aging and Body Composition Study. Associations of erythropoietin with incident HF, coronary heart disease, stroke, mortality, and ≥ 30% decline in estimated glomerular filtration rate were examined using Cox proportional hazards and logistic regression over 10.7 years of follow-up. Mean (SD) age was 75 (3) years and median (quartile 1, quartile 3) erythropoietin was 12.3 (9.0, 17.2) mIU/mL. There were 503 incident HF events, and each doubling of serum erythropoietin was associated with a 25% increased risk of incident HF 1.25 (95% confidence interval 1.13, 1.48) after adjusting for demographics, prevalent cardiovascular disease, cardiovascular disease risk factors, kidney function, and serum hemoglobin. There was no interaction of serum erythropoietin with chronic kidney disease or anemia (P > 0.50). There were 330 incident coronary heart disease events, 161 strokes, 1112 deaths, and 698 outcomes of ≥ 30% decline in estimated glomerular filtration rate. Serum erythropoietin was not significantly associated with these outcomes. CONCLUSIONS: Higher levels of endogenous erythropoietin are associated with incident HF in older adults. Studies need to elucidate the mechanisms through which endogenous erythropoietin levels associate with specific outcomes.
BACKGROUND: Studies suggest that in patients with heart failure (HF), high serum erythropoietin is associated with risk of recurrent HF and mortality. Trials of erythropoietin-stimulating agents in persons with kidney disease have also suggested an increased incidence of adverse clinical events. No large studies of which we are aware have evaluated the association of endogenous erythropoietin levels with clinical outcomes in the community-living older adults. METHODS AND RESULTS:Erythropoietin concentration was measured in 2488 participants aged 70-79 years in the Health, Aging and Body Composition Study. Associations of erythropoietin with incident HF, coronary heart disease, stroke, mortality, and ≥ 30% decline in estimated glomerular filtration rate were examined using Cox proportional hazards and logistic regression over 10.7 years of follow-up. Mean (SD) age was 75 (3) years and median (quartile 1, quartile 3) erythropoietin was 12.3 (9.0, 17.2) mIU/mL. There were 503 incident HF events, and each doubling of serum erythropoietin was associated with a 25% increased risk of incident HF 1.25 (95% confidence interval 1.13, 1.48) after adjusting for demographics, prevalent cardiovascular disease, cardiovascular disease risk factors, kidney function, and serum hemoglobin. There was no interaction of serum erythropoietin with chronic kidney disease or anemia (P > 0.50). There were 330 incident coronary heart disease events, 161 strokes, 1112 deaths, and 698 outcomes of ≥ 30% decline in estimated glomerular filtration rate. Serum erythropoietin was not significantly associated with these outcomes. CONCLUSIONS: Higher levels of endogenous erythropoietin are associated with incident HF in older adults. Studies need to elucidate the mechanisms through which endogenous erythropoietin levels associate with specific outcomes.
Authors: Wendy P J den Elzen; Jorien M Willems; Rudi G J Westendorp; Anton J M de Craen; Gerard Jan Blauw; Luigi Ferrucci; Willem J J Assendelft; Jacobijn Gussekloo Journal: CMAJ Date: 2010-12-14 Impact factor: 8.262
Authors: Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima Journal: Arch Intern Med Date: 2008-10-27
Authors: Javed Butler; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Rhonda Belue; Nicolas Rodondi; Melissa Garcia; Douglas C Bauer; Suzanne Satterfield; Andrew L Smith; Viola Vaccarino; Anne B Newman; Tamara B Harris; Peter W F Wilson; Stephen B Kritchevsky Journal: Circ Heart Fail Date: 2008-07 Impact factor: 8.790
Authors: Karl Swedberg; James B Young; Inder S Anand; Sunfa Cheng; Akshay S Desai; Rafael Diaz; Aldo P Maggioni; John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Scott D Solomon; Yan Sun; Michal Tendera; Dirk J van Veldhuisen Journal: N Engl J Med Date: 2013-03-10 Impact factor: 91.245
Authors: Peter van der Meer; Adriaan A Voors; Erik Lipsic; Tom D J Smilde; Wiek H van Gilst; Dirk J van Veldhuisen Journal: J Am Coll Cardiol Date: 2004-07-07 Impact factor: 24.094
Authors: Kushang V Patel; Dan L Longo; William B Ershler; Binbing Yu; Richard D Semba; Luigi Ferrucci; Jack M Guralnik Journal: Br J Haematol Date: 2009-03-05 Impact factor: 6.998
Authors: Jalal K Ghali; Inder S Anand; William T Abraham; Gregg C Fonarow; Barry Greenberg; Henry Krum; Barry M Massie; Scott M Wasserman; Marie-Louise Trotman; Yan Sun; Beat Knusel; Paul Armstrong Journal: Circulation Date: 2008-01-14 Impact factor: 29.690
Authors: Pengfei Sun; Nitin Kumar; Adrienne Tin; Jing Zhao; Michael R Brown; Zesen Lin; Min-Lee Yang; Qiwen Zheng; Jia Jia; Lawrence F Bielak; Bing Yu; Eric Boerwinkle; Kristina L Hunker; Josef Coresh; Y Eugene Chen; Yong Huo; Sharon L R Kardia; Rami Khoriaty; Xiang Zhou; Alanna C Morrison; Yan Zhang; Santhi K Ganesh Journal: Hypertension Date: 2021-09-07 Impact factor: 10.190
Authors: Nadezda V Andrianova; Marina I Buyan; Anastasia K Bolikhova; Dmitry B Zorov; Egor Y Plotnikov Journal: Front Physiol Date: 2021-07-06 Impact factor: 4.566
Authors: Vanessa De la Cruz-Góngora; Aarón Salinas-Rodríguez; Salvador Villalpando; Mario Flores-Aldana Journal: Nutrients Date: 2019-04-30 Impact factor: 5.717